100%(1)100% fanden dieses Dokument nützlich (1 Abstimmung)
237 Ansichten6 Seiten
The document discusses various types of viral hepatitis including Hepatitis A, B, and C. It provides details on the causes, clinical manifestations, diagnostic findings, prevention, and management of each type of hepatitis. Key points include that Hepatitis A is typically acquired through fecal-oral transmission and causes an acute, self-limiting infection. Hepatitis B can become chronic and lead to cirrhosis or liver cancer if acquired early in life. Hepatitis C often results in chronic liver disease and is a major cause of liver transplants. Prevention strategies include vaccines for Hepatitis A and B.
The document discusses various types of viral hepatitis including Hepatitis A, B, and C. It provides details on the causes, clinical manifestations, diagnostic findings, prevention, and management of each type of hepatitis. Key points include that Hepatitis A is typically acquired through fecal-oral transmission and causes an acute, self-limiting infection. Hepatitis B can become chronic and lead to cirrhosis or liver cancer if acquired early in life. Hepatitis C often results in chronic liver disease and is a major cause of liver transplants. Prevention strategies include vaccines for Hepatitis A and B.
Copyright:
Attribution Non-Commercial (BY-NC)
Verfügbare Formate
Als DOCX, PDF, TXT herunterladen oder online auf Scribd lesen
The document discusses various types of viral hepatitis including Hepatitis A, B, and C. It provides details on the causes, clinical manifestations, diagnostic findings, prevention, and management of each type of hepatitis. Key points include that Hepatitis A is typically acquired through fecal-oral transmission and causes an acute, self-limiting infection. Hepatitis B can become chronic and lead to cirrhosis or liver cancer if acquired early in life. Hepatitis C often results in chronic liver disease and is a major cause of liver transplants. Prevention strategies include vaccines for Hepatitis A and B.
Copyright:
Attribution Non-Commercial (BY-NC)
Verfügbare Formate
Als DOCX, PDF, TXT herunterladen oder online auf Scribd lesen
systemic, viral infectnecrosis & inflam of liver cells
* clinical, biochemical, & cellular A adult pop. < 25% of kids -antibodies to HAV HAV antibody ^ w/ age, & ppl 50 + -prior exposure. Hepatitis A Virus infectious hepatitis gCxRNA virus (Enterovirus) fecaloral route, - In BM b4 start of sx & during 1 st few days of illness. shellfish from sewage-contaminated waters. g incubation period 15 & 50 days -mean :28 -30 days Can last 4- 8 wks longer & more sev 40+ most recover & rarely progresses to acute liver necrosis or fulminant hepatitis cirrhosis of liver or death. carrier & chronic hepatitis virus-briefly in serum,when jaundice occurs noninfect Clinical Manifestations g jaundice anicteric asx sx mild, *F-like URInfect, low-F*. A*( early sx) g cx release of toxin by damaged liver or failure of damaged liver cells to detoxify an abn product. g Later, jaundice & dark urine Indigestionvague epigastric distress, *N, burn,& flatulence. strong aversion to taste of cigs or presence of cig smoke & other strong odors. g sx clear jaundice reaches its peak10 days after sx mild in kids; adults more severe, & longer. Assessment & Diagnostic Findings g liver & spleen mod enlg few days after onset; Hepatitis A antigen in BM 7 -10 days B4 illness & 2-3 wks after sx. HAV antibodies serum, not until sx immunoglob anal antibodyacute or past infect . Prevention g vaccine Havrix & Vagta Protection w/in several wks after 1 st dose g Immune globulin may suppress sx disease ]Caution w. previous angioedema, hives, or other allergic reactions immune globulin Epinephrine allergic reaction. Medical Management Bed rest acute stage & diet restriction of phys activity. During A* , freq small feedings, supl IV fluids with glucose. Gradual but progressive ambulation hasten recovery, Nursing Management Home unless sev. Teach +/R for contracting HAV Hepatitis B Virus blood (percutaneous & permucosal routes) blood, saliva, semen, & vag secretions transmit mucous memb &opening skin or infect moms long incubation period reproduces in liver & in serum long time transmis g contract HBV infectdevelop antibodies & recover spontaneously in 6 mos. Mortality: up to 10%. g HBV progress to carrier state or develop chr hepatitis w/ persistent HBV infect & hepatocell injury & inflam. g major cx of - cirrhosis & hepatocellular carcinoma. old ^/R-sev liver cell necrosis or fulminant hepatic fail Elim alterations to liver fx meds, OH Clinical Manifestations incubation 1 -6 mos F* & resp sx-rare arthralgias & rashes. + appetite, dyspepsia, abd pain, aching, malaise, & weak. may(not)-Jaundice light-colored stools & dark urine liver- tender & enlg 12-14 cm vertically. spleen is enlg & may b palpable posterior cervical lymph nodes may b enlg Assessment & Diagnostic Findings HBV is a DNA virus antigenic particles: - HBcAgB core antigen (in inner core) - HBsAgB surface antigen (on viral surface, a marker of active replication & infect ) - HBeAgan independent protein circulating in blood - HBxAggene product of X gene of HBV DNA Ea. antigen elicit its specific antibody & marker in diff stages - anti-HBcantibody to core antigen of HBV; acute phase may indicate continuing HBV in liver -anti-HBsantibody to surface determinants on HBV; late convalescence; indicates recovery & development of immunity -anti-HBeantibody to hepatitis B e-antigen; + infect -anti-HBxAgantibody to hepatitis B x-antigen; ongoing replication of HBV Active Immunization: Hepatitis B Vaccine Recommend ^/R HBV HCV & chr liver diseases g A yeast-recombinant hepatitis B vaccine (Recombivax HB) active immunity booster hemodialysis & some immunocompromised 3 deltiod IM doses; 2 nd & 3 rd 1 & 6 months Antibody response - anti-HBs levels 1- 3 mos after Passive Immunity: Hepatitis B Immune Globulin (HBIG) passive immunity to hep B & for exposed to HBV who have never had hep. B & hep B vaccine. Specific indications postexposure vaccine with HBIG (1) exposure needlestick or splashes w. mucous memb (2) sex w. positive for HBAg (3) babies born to HBV-moms given HBIG w.in 12 hrs HBIG plasma - high titers of anti-HBs. active & passive immunization w. exposed HBV Medical Management Goals + infectivity & liver inflam & + sx. alpha-interferon inject s/eF*,chills, A* , *N, myalgias, & fatigue . Delayed s/emore serious+ dose or dc B] suppress, thyroid dysfx, alopecia, & bacterial infect g antiviral agents, lamivudine (Epivir) & adefovir (Hepsera), oral nucleoside analogues, seroconversion rates, loss of detectable virus, liver fx, & + progres to cirrhosis w/ lamivudine. decompensat cirrhosis wait 4 liver transplant Adefovir effective in ppl resistant to lamivudine. Bed rest until sx of hepatitis have subsided. Activities -restricted hepatic enlrg & ^ bilirubin & liver enzymes have disappeared Gradually ^ activity Adequate nutrition Proteins restricted- impaired liver to metabolize protein byproducts control dyspeptic sx & general malaise antacids & antiemetics meds w. V* - V*persistshosp & fluid therapy ^/R HIV Nursing Management Prolonged recovery from complete sx up to 3-4 mos + gradual resume of physical encr after jaundice Teaching Self-Care prolonged recov period home care. rest & nutrition make arrangement receive hepatitis B vaccine or hepatitis B immune globulin Hepatitis C Virus blood transfusions & sex, needles + underlying cx 1/3 of hepatocellular carcinoma, & most common reason for liver transplant incubation period variable-15 -160 d. ^/R-chronic liver diseasecirrhosis or liver cancer Small OH progression benefit from rest, diet, or vitamin supplements. g antiviral agents, interferon (Intron-A) & ribavirin (Rebetol) HCV & in tx relapses. Hemolytic anemia, freq s/e severe d/c Ribavirin caution -childbear Molecule polyethylene glycol moiety (PEG) is added to interferon keep it in body longerextends dose- 1/wk Pegylated interferon (Pegasys) virologic response rate
Hepatic Cirrhosis replacement of normal liver tissue w/ diffuse fibrosis that disrupts structure & fx of liver. Alcoholic cirrhosis scar tissue surrounds portal Postnecroticbroad bands of scar tissue. late result of prev acute viral hepatitis. Biliary scarring in liver around bile ducts. Cxchronic biliary obstruct & infect (cholangitis) scarportal & periportal spaces, where bile canaliculi of each lobule communicate to form liver bile ductssites of inflam, & bile ducts occluded w/ thick bile & pus liver form new bile channels overgrowth of disconnected, newly formed bile ducts & surrounded by scar tissue. SX intermittent jaundice & F* initial liver enlg , hard, & irregular atrophies. Pathophysiology Course- 30 or more years. +protein intakeliver destruct cirrhosis, ^OHfatty liver chem(carbon tetrachloride, chlorinated naphthalene, arsenic, or phosphorus) or infectious schistosomiasis. OHic cirrhosis necrosis- destroyed liver cells gradually replaced by scar tissueexceeds liver fx Clinical Manifestations Coampensated cirrhosis, w/ less severe, vague sx, decompensated cirrhosis failure of liver to synthesize proteins, clotting fx, & other substances & sx of portal ^BP, ascites, varices, & hepatic encephalopathy Liver Enlargement Earlyliver lrg & cells-loaded w/ fat. firm & sharp edge. abd pain recent, rapid enlg of liver tension on fibrous covering of liver (Glisson's capsule). Later liver +- scar tissue contracts liver. - liver edge, if palpable, is nodular. Portal Obstruction & Ascites Cx chr failure of liver fx & obstruct of portal circulation. most of blood from digestive organs is collected in portal veins & carried to liver cirrhotic liver free blood passage blood backs up into spleen & GI tract, chr passive congestion Indigestion & alt bowel fx result. protein e ^^ in peritoneal cavity ascites percussion shifting dullness or fluid wave Infect & Peritonitis w/ cirrhosis & ascites in absence of an intra-abdominal source of infect or an abscessspontaneous bacterial peritonitis (SBP). Bacteremia intestinal flora sx- Dxparacentesis + Antibx tx & prevention of recurrent episodes of SBP. - hepatorenal synd functional renal fail -unresponsive to admin of e or diuret - (sev comp) lack patho in kidney, dehyd or obstruct of urinary tract or any other renal disorder. Gastrointestinal Varicesobstruction to blood flow through liver fibrotic & form blood vessels in GI blood shunts from portal vessels into blood vessels w/ lower pressures distended abd vesselsvisable (caput medusae), & distended vessels throughout GI tract. Esophagus, stomach, & lower rectum distended blood vessels form varices or hemorrhoids, cant tol high pressure & vol of blood rupture & bleed. g assessobserv-occult & frank bleeding from GI tract. Edema Late sxchronic liver failure. g + plasma albumin dependent edema not Facial ^ aldosterone Na & H20 reten & K excretion. Vitamin Deficiency & Anemia Inadeq form, use, & storage of vit(A, C, & K) g hemorrhagic phenomena K defic. g Chr gastritis & GI fx, w/ poor diet intake & liver fxanemia assoc w/ cirrhosis. Mental Deterioration & cog fx w/ impending hepatic encephalopathy & hepatic coma. g nuero assess behavior, cog abilities, orient & speech. Assessment & Diagnostic Findings g Sev parenchymal liver dysfx+albumin & ^ globulin g Enzyme tests liver cell damage ^: ALP, AST, ALT, & GGT, & + cholinesterase g Bilirubin tests: bile excretion or retention ^ bilirubin cirrhosis & other liver disorders. g PT time prolonged. g US diff. in density of parenchymal cells & scar tissue. g CT, MRI, & radioisotope liver scans liver size & hepatic blood flow & obstruction. g DXliver biopsy. g blood gas V/Q imbal & hypoxia. Medical Management + antacids or H 2 antag + gastric distress & GI bleeding. + Vit & nutritional supps healing of damaged liver cells & nutritional status. + K-sparing diuretics(Aldactone) or (Dyrenium) + ascites, + F/E - colchicine, (anti-inflam gout) survival in w/ OHic liver disease or mild-mod cirrhosis g end-stage liver disease (ESLD) w/ cirrhosis herb milk thistle (Silybum marianum) to tx jaundice g Primary biliary cirrhosis tx w/ ursodeoxycholic acid to liver . Acute Pancreatitis mild, self-limited sev, rapidly fatal- respond to tx Mild acute edema & inflam of pancreas. Min organ dysfx, & return to NRM fx w/in 6 mos pat is acutely ill & @/r +vol shock, F/E disturb& sepsis enzymatic digestion of gland acute pancreatitis. Enzymes damage local blood vessels bleeding & thrombosistissue necrotic into retroperitoneal tissues. Local compl pancreatic cysts or abscesses & acute fluid collections in or near pancreas. Sev acute systemic compl w/organ fail, pulm insuff w/ hypoxia, shock, renal fail, & GI bleed Pathophysiology g cxSelf-digestion of pancreas by own enzymes trypsin biliary tract disease; gallstones pancreatitis Gallstones enter common bile ductobstruct flow of pancr. juice or causing a reflux of bile from bile duct into pancr. duct activating powerful enzymes w/in pancreas. inactive until pancreatic secretions reach duodenum. g Activation of enzymes vasodilation, ^ vascular perm, necrosis, erosion, & hemorrhage undx- chr pancreatitis B4 1 st epis of acute pancreatitis. cx bacterial or viral infect , compl. of mumps virus. Spasm & edema of ampulla of Vater from duodenitis, Blunt abd trauma, peptic ulcer, ischemic vascular, ^lipidemia, Ca, & use of corticost, thiazide diuret, contraceptives- ^/R-pancreatitis. may develop after surgery on or near pancreas or after instrumentation of pancreatic duct. Mortality shock, A*, +BP, or F/E imbal Attacks may result in complete recovery, w/o permanent damage, or chronic pancreatitis. outcomes clinical & labs Clinical Manifestations g sev abd pain & tenderness & back pain irritation & edema of inflamed pancreasstimulate nerve endings. ^ tension on pancreatic capsule & obstruction of pancreatic ducts midepigast pain -24 -48 hrs after a heavy meal or OH, & difficult to localize. g unrelieved by antacids abd distention; a poorly defined, palpable abd mass; & + peristalsis. g Abd guarding, board-like abd or soft w/o peritonitis. g Bruise-flank or umbilicus sev pancreatitis. *N & V*gastric or bile-stained. F*, jaundice, confusion, & agitation + BP+vol & shock loss of a lot protein-rich fluid tissues & peritoneal cavity. ^P, cyanosis, & cold, clammy skin. A.Rnl.F . Resp distress & hypoxia, diffuse pulm infiltrates, SOB, ^R, & abn ABG. g Myocardial depression, + Ca, ^BS, DIC Assessment & Diagnostic Findings g DX Hx-abd pain, risk fx , psy exam g Surum amylase & lipase -3x normal limit w.in 24 hrs amylase returns to normal w/in 48-72hrs lipase may remain elevated for 5 - 7 days g Urinary amylase ^ & ^longer than serum amylase g WBC ^ g ^Ca- severity g ^BS & glucosuria & ^ bilirubin g X-ray of abd & chest differentiate pancreatitis from other disorders & to detect pleural effusions. g U/S & CT scans^ in diameter of pancreas & to detect pancreatic cysts, abscesses, or pseudocysts. g Hct & Hbg bleeding. g Peritoneal fluid (paracentesis or peritoneal lavage) ^ pancreatic enzymes. g BM bulky, pale, & foul Fat content 50% & 90% Med Managementrelieving sx & preventing or tx comp. g oral intake to inhibit stim of pancreas & its secretion of enzymes. g TPN extreme metab stress enteral route preferred - prevent infect comp, - tolerate parenteral nutrition. NG suxN &V + painful abd disten & paralytic ileus. gH 2 antag Tagamet &Zantac+pancr. activity by inhib HCl secretions g Proton pump inhibProtonix- tol H 2 or ineffect Pain Management g analgesia pain relief &+restlessstim panc secretion g IV opioids morphine Dilaudid g Antiemetic Intensive Care Correction of fluid & blood loss & + albumin maintain fluid volume & prevent Rnl.F. monitorhemodynamic & ABG Antibx infect Insulin g continuous infusion critically ill Respiratory Care Aggressive resp care ^/R - ^ diaphragm, pulm infiltrates & effusion, & atelectasis. g Hypoxemia humidify O2 to intubation & mech vent Biliary Drainage g biliary drains & stents pancreatic ductendoscopy + pain & ^ weight gain. Surgical Intervention risky g (diagnostic laparotomy) establish pancr drainage resect or dbride necrosis. mult. drains & incision left open for irrigation & repacking q. 2 -3 days to remove necrotic debris Postacute Management - Antacids after it resolve. - Oral feedings low fat & protein gradually. - Caffeine & OH Follow-up U/S, x-ray studies, or ERCP resolving /abscesses /pseudocysts. ERCP cause & endoscopic sphincterotomy & removal of gallstones from common bile duct. Chronic Pancreatitisg imflam disorder g progressive anat & fx destruction of pancreas. As cells are replaced by fibrous tissue w/ repeated attacks of pancreatitis, pressure w/in pancreas mech obstruct of pancreatic & common bile ducts & duodenum. atrophy of epithelium of ducts, inflam, & destruction of secreting cells of pancreas. g LT OHic ^secretion of protein in pancreatic secretionsprotein plugs & calculi w/in pancreatic ducts. Clinical Manifestations g recurring attacks of sev. upper abd & back pain, w/ V*. opioids may be ineffect. Progression pain attacks more sev, freq & longer cont. sev pain or dull, nagging constant pain. - 20% severe painless Weight loss +intake 2 nd to A* or fear attack g Malabsorption late proteins & fats - impaired. g BM, freq, frothy, & foul- impaired fat g steatorrhea high fat content Progression calcification of gland, & Ca stones w/in ducts Assessment & Diagnostic Findings ERCP Dx-detail about anat of pancreas & ducts - tissue 4 anal & diff. from other conditions (carcinoma) g MRI g CT scans, & u/sdetect pancreatic cysts. g glucose tolerance test pancreatic islet cell fx info needed 4deciding on surgical resection of pancreas. abn glucose tolerance test diab assoc w/ pancreatitis. - Acute exacerbations ^ serum amylase levels. Medical Management Depends on cause prevent & manage acute attacks, relieving pain & discomfort, & manage exocrine & endocrine insuffic of pancreatitis. Nonsurgical Management gEndoscopy remove pancreatic duct stones & strictures manage pain & relieve obstruction g abd pain & discomfort nonopioid avoid OH & foods abd pain & discomfort in past. hazard sev + BS w/ OH is stressed g Pancreatic enzyme replace w/ malabsorp & steatorrhea. g proton pump inhib Prilosec, Prevacid w/ enzyme therapy + gastric acid inactivation of enzymes Surgical Managementrelieve abd pain & discomfort, restore drainage of pancreatic secretions, & + freq of acute attacks of pancreatitis. g type depends on anatomic & fx abnorm of pancreas location w/in pancreas, diab, exocrine insuffic, biliary stenosis, & pseudocysts of pancreas Cont use of OH? Ability to manage endocrine or exocrine after surgery. NOTES from elsewhere You are assigned to care for a 35-year-old writer who has been admitted with severe upper abdominal pain radiating to his back & recurrent vomiting. This is his second admission for pancreatitis. He admits to drinking 1 pint of whiskey daily on the weekends & having several drinks nightly on weekdays. His alcohol intake has been greater in the past. Laboratory data include an amylase level of 750 units/L (normal, 25 to 125 units); lipase is 5.6 units/ml (normal, 10 to 140 units); aspartate aminotransferase (AST), 150 units/L ( normal 10-40) & alanine aminotransferase (ALT), 60 units (normal 5-350 WBC 16,000, BUN 34mg/dl, BS 324 mg/dl; serum Ca was 7.2 mg/dl & his K is high. Hgb dropped from 13.2 to 10.8, serum proteins low & serum bili is mildly elevated at 2mg/dl. Do the lab studies support a diagnosis of pancreatitis? Explain. levels ^ in blood when pancreas is damaged. Amylase enzyme - starch to sugar lipase enzyme- fats to fatty acids & glycerol Lipase peaks in 24 hrs then + May have chronic fibrosis from OH (length & degree) lipase + bc of scarring. Analyze the lab studies. g AST-enzyme present in tissues of high metabolic activity & is released into blood following the injury of death of cells) - in this case damage to pancreas & liver possibly. g ALT ^- obstructive jaundice or biliary disease. g+ Ca Ca forms complexes w/ fatty acids musc twitching, tetany, & numb-mouth, irreg g ^ BS (324) stress & insulin secretion being disrupted by damaged beta cells in pancreas. g ^BUN (34) dehydration. g ^WBC inflam process - clean up crew needed g ^K cell breakdown & dehyd g + hgb- retroperitoneal bleeding (abd blood loss) from autodigestion of pancreas. g Serum bili mildly ^ obstruct common bile duct(inflam process & pressure from inflamed pancreas)& RBC destruct Pancreatitis patho Obstruction to the outlow of pancreastic enzymes by bile, pancreatic duct obstruction itself(edema) or reflux permit leakage of pancreatic juices containing enzymes into pancreatic tissue - g autodigestion pancr enzymes cause destruction of pancreatic tissue & hemorrhage & tissue necrosis. OH use^ pancr enzymes constrict of pancr sphincter. symptoms of pancreatitis Severe LUQ epigastic pain back Rigidity &guarding sitting &leaning forward may help. - Pain worse -lying down & may pull up L leg- comfort +/absent bowel sounds + digestion. N&V buildup of gas & + intestinal activity. Turner (flanks) &Cullen (umbilicus) sx retroperitonea bleeding possibly peritonitis. Jaundicedinflamed pancreas pressing on bile duct Clay colored stools + fat absorption enzymes not getting to duodenum ^BS impaired insulin secret & unable to use glucose. Tetany + Ca ^/+BPdepending on level of shock, ^P, ^ low- temp compensatory response to inflam & F/E imbal Volume deficit + intake & possible 3 rd space inflamed pancreas can sequester e to the site, blood loss. How does acute pancreatic differ from chronic? Acute varying degrees of edema, hemorrhage & necrosis, & shock. ^ lab values. Chronic progressive destructive of pancreas w/ milder chronic inflam & may not have ^labs The labs are called to the Dr. New orders are to T & C for 2 units of PRBCs. Mg level with next blood draw, BS q 4 hrs. with coverage per protocol, keep an amp of calcium gluconate at bedside, NG to suction, Consult with pharmacy & dietician, I O, VS q 4 rationale for these orders? Any other orders you might anticipate or want to ask the Dr. about? g + hgb may need blood. g Mg + is common in OHics abuse. Low g + calcium w/ + mg levels. tetany to laryngiospasms . Emergency Ca gluconate tx. g Monitor BS & tx w/ insulin g NG +distention & gas but primarily to + stim of pancreas release of more enzymes more autodigestion, necroisis & hemorrhage. g IV order- TPN or jejunal feedings vit replacement g Antacids Zantac g Antichol-Bentyl, Lomine Watch for DTs Surgery maybe to remove gall bladder if cause ERCP open blocked bile duct What do you need to consider if he complains of pain? Allergies g PCA Morpine best method. Chronic pancr often can not receive adequate pain control. positioning, imagery, relaxation, controlling envir stim g Surgical interv cut nerves to pancreas to + pain. complications from pancreatitis that may occur? g Shock & multiple organ failure release of bacterial endotoxins injury to vessels, kidneys & lungs g Pleural effusions & respiratory compromise. g Pancreatic pseudocyst or abscess What are common patient education needs? Stop drinking all together if OH induced pancreatitis. limit drinking for 3 months. g Previous damage fiborosis cannot be reversed. + fat diet if deficient in pancreatic lipase. pancreatic enzyme replacement 1/3 b4 meals & rest during meals in cases of chronic pancreatitis. educ how to take the enzymes. Hepatitis Etiology & Pathophysiology inflam of liver 2 nd to infection, parasitic infestation, OH, toxins, drugs (INH, acetaminophen) Afecal-oral; 2nd to sanitation & eating shellfish from contaminated water B & C w/ contaminated blood; 2 nd sex, sharps R/ Fx Health care -druggies - mult sex. Hemophiliacs freq transfusions of clotting fx 30% have unidentifiable sources Signs & Symptoms May be asymptomatic Preicteric stage: Flulike symptoms Icteric stage: N&V, A, malaise, jaundice, presence hepatitis antigens & antibodies; aspartate aminotransferase AST, alanine aminotransferase (ALT) Treatment Antivirals (interferon) Vaccines against HAV & HBV b4 exposureactive immunity Immune globulins passive immunity post exposure Nursing Monitor S&S Calories, protein, fat diet as ordered Contact precautions for HAV & HEV educ avoid toxins (Tylen, OH, carbon tetrachloride, INH) g Hepatic encephalopathy: precipitating fx g HEPATICS: Hemorrhage in GIT/ Hyperkalemia Excess protein diet Paracentesis Acidosis/ Anemia Trauma Infection Colon surgery Sedatives g Pancreatitis (acute): GET SMASHED: Gallstones Ethanol Trauma Steroids Mumps Autoimmune (PAN) Scorpion stings Hyperlipid-^Ca ERCP Drugs (including azathioprine and diuretics) g PANCREAS: PaO2 below 8 Age >55 Neutrophils: WCC >15 Ca < 2 Renal: Urea >16 Enzymes: LDH >600 ~AST >200~ Albumin < 32 Sugar: Glucose >10 (unless diab) g LEGAL: Leukocytes > 16.000 Enzyme AST > 250 Glucose > 200 Age > 55 LDH > 350 Cirrhosis Etiology & Pathophysiology Fibrous scar tissue & fat accumulate in liverhepatomegaly & portal ^BP esophageal varices, hemorrhoids, obstructive jaundice & ascites Liver fx metabolism ammonia (a metabolized protein by-product) encephalopathy Risk Factors OHics, hepatitis or biliary disease Industrial chemicals, male gender, 40-60yr old Signs & Symptoms Liver enzymes (AST, ALT, LDH, GGT), jaundice, hepatomegaly Albumin, bilirubin, globulins, ammonia, PT Ascites, GI varices, edema 2 nd to albumin & aldosterone, retention of Na & H2O Confusion, agitation, flapping hand tremors (asterixis) Liver biopsy to confirm diagnosis Treatment Vitamins (A, D, E, K, B), zinc, colchicine, K sparing diur Lactuloseammonia; albumin Portal caval shunt, sclerotherapy/ balloon tamponade varices Paracentesis for ascites w/ dyspnea Nursing Monitor S&S, I&O, abd girth Liver biopsy: pat hold breath during needle insertion; keep on right side w/ pillow against insertion site. Assess for bleeding Paracentesis: void b4 & maintain an upright position during procedure; after assess resp status, Sx of shock, persistent leakage Balloon tamponade: Provide oral suction, maintain traction on gastric balloon, - pressure of esopg balloon Pancreatitis: Inflam of the pancreas activation of pancr enzymes w.in the pancr self-digesting Obstruction of pancreatic duct reflux of trypsin autodigestion inflam Possible necrosis w/ calcification, perforation, or hemorrhage Pancreatic pseudocysts or abscesses may develop May be idiopathic, acute or chronic & result in DM Acute suddenly & w/o warning. Chronic graduallyyears, w/ initial sx-vague Cause: gallstones & OH. Acute chronic once pancreatic tissue is destroyed & scarring develops. ^lipidemia, Ca, abd trauma, & bacterial /viral infection. Signs & Symptoms Extremely high triglycerides (1000mg/dL) Abd pain that w/ eating & thorax/back ^ supine abd distendworse after eat, jaundice N,V, F, &^P Steatorrhea & glucose intol w/ chronic pancreatitis Amylase, lipase, Ca S&S of perforation Rebound tendern, rigid abd, shock Nursing Focus is supportive care & the prevention of 2 nd comp. Assess labs: ^ levels of amylase & lipase. Vit A & E, & fat diet as ordered Provide small freq meals. - BS, Ca Mg Na K & HCO3. Patient Teaching Teach Pt to avoid OH & + foods high in fat. Provide educ prior to dx proceduresabd u/s-gallstones & a CT -inflam & destruction of the pancreas. Treatment NPO, IVF & electrolyte replacement NGT to GI motility & secretions Antibx, anticholinergics, pancreatic enzymes (lipase, trypsin, amylase) w/ meals for chronic Surgery if 2 nd to biliary disease Cholecystitis Etiology & Pathophysiology bile flow gallbladder inflam (cholelithiasis), distention, & autolysis gangrene or perforation blocked bile flow may obstructive jaundice Usually 2 nd to gallstones or other precipitates Risk Factors 4 Fs: fair, fat, 40, female Rapid weight, cirrhosis Estrogen therapy Mult preg DM Signs & Symptoms RUQ abd painback, shoulder esp. after fat meal N&V, T, rebound tender, obstructive jaundicedark urine, & clay-colored stools sx bleedfat digestabsorpt of the fat soluble vit K WBC, bilirubin, alkaline phosphatase Treatment Laparoscopic or abd removal of gallbladder (cholecystectomy) Incision into common bile duct (choledochostomy) Dissolution of stones by oral chenodiol or infusion of solvent into gallbladder Nursing Monitor S&S Teach fat diet; IS & coughing (incision near diaphragm) Preoperative vit K, analgesics Maintain T-tube drainage if bile duct explored. Tube removedbrown BMbile flow
DR Kumar Ponnusamy Biochemistry-Genetics USMLE Preparatory Course BIOGEN Reusable On-Line Resources For Large Group Teaching-Learning in Relatively Short Time